Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Interest & Investment Income (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Interest & Investment Income for 11 consecutive years, with $552000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 47.99% to $552000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 88.4% year-over-year, with the annual reading at $2.1 million for FY2025, 88.4% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $552000.0 at Niagen Bioscience, down from $564000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $564000.0 in Q3 2025, with the low at $125000.0 in Q2 2023.
  • Average Interest & Investment Income over 3 years is $350090.9, with a median of $282000.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income surged 32.27% in 2024, then soared 129.05% in 2025.
  • Over 3 years, Interest & Investment Income stood at $282000.0 in 2023, then surged by 32.27% to $373000.0 in 2024, then soared by 47.99% to $552000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $552000.0, $564000.0, and $552000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.